Technology
Health
Biotechnology
Mesoblast
$5.249876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$5.24
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.03 (-0.57%) Today
-$0.01 (-0.19%) As of 4:00 PM EDT after-hours
Why Robinhood?
You can buy or sell Mesoblast and other stocks, options, ETFs, and crypto commission-free!
About MESO
Mesoblast Limited American Depositary Shares, also called Mesoblast, is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target the cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. Read More The company was founded by Itescu Silviu on June 8, 2004 and is headquartered in Melbourne, Australia.
Employees
81
Headquarters
Melbourne, Victoria (VIC)
Founded
2004
Market Cap
518.89M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
99.52K
High Today
$5.29
Low Today
$5.21
Open Price
$5.29
Volume
10.78K
52 Week High
$8.78
52 Week Low
$3.35
Collections
Technology
Health
Biotechnology
Biopharmaceutical
Pharmaceutical
MESO News
Price Paid on Robinhood
5% Lower
Right Now
52 Week Low
$3.35
Average Price Paid
$5.51
52 Week High
$8.78
Analyst Ratings
86%
of 7 ratings
Buy
86%
Hold
14%
Sell
0%
MESO Earnings
-$0.26
-$0.18
-$0.10
-$0.02
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
—
Actual
Expected Aug 28, After Hours